MODULATORS OF TNF-α ACTIVITY
Patent Information
- Application Number
- ARP20250100848
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-23
- Filing Date
- 2025-04-01
- Publication Date
- 2026-10-07
Claims
A compound of formula (1) or a pharmaceutically acceptable salt, solvate, deuterium isotope, or N-oxide thereof. A pharmaceutical composition comprising the compound or pharmaceutically acceptable salt, solvate, or N-oxide thereof of any of claims 1-47 and a pharmaceutically acceptable excipient or carrier. A method for preparing a pharmaceutical composition comprising mixing the compound or pharmaceutically acceptable salt, solvate, or N-oxide thereof of any of claims 1-47 and a pharmaceutically acceptable excipient or carrier. A pharmaceutical composition comprising the compound or pharmaceutically acceptable salt, solvate, or N-oxide thereof of any of claims 1-47, for use in an inflammatory or autoimmune disease or disorder in a patient in need thereof. A compound of formula (A) or a pharmaceutically acceptable salt, solvate, deuterium isotope, or N-oxide thereof.